Schreiner MediPharm integrates NFC for digital authentication of autoinjectors

Schreiner MediPharm is introducing an NFC-enabled label designed for digital authentication of autoinjectors. Although the EU Falsified Medicines Directive (FMD) requires pharmaceutical manufacturers to serialize products and provide secondary product packaging with an anti-tampering device, Schreiner MediPharm noted that there is not yet a comparable requirement for primary containers and devices for self-medication, such as pens and autoinjectors. This has led it to develop the NFC label for autoinjectors, in combination with a corresponding smartphone app that unequivocally informs users if the product is still in its originally sealed condition.